155 related articles for article (PubMed ID: 7651739)
21. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
22. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
[TBL] [Abstract][Full Text] [Related]
23. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
[TBL] [Abstract][Full Text] [Related]
24. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
[TBL] [Abstract][Full Text] [Related]
25. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
[TBL] [Abstract][Full Text] [Related]
26. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
27. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
[TBL] [Abstract][Full Text] [Related]
28. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
[TBL] [Abstract][Full Text] [Related]
29. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
Wu HK; Weksberg R; Minden MD; Squire JA
Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
[TBL] [Abstract][Full Text] [Related]
30. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
31. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
[TBL] [Abstract][Full Text] [Related]
32. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
33. Monoalleleic transcription of the insulin-like growth factor-II gene (Igf2) in chick embryos.
Koski LB; Sasaki E; Roberts RD; Gibson J; Etches RJ
Mol Reprod Dev; 2000 Jul; 56(3):345-52. PubMed ID: 10862000
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
[TBL] [Abstract][Full Text] [Related]
35. Monoallelic expression of IGF2 at the human fetal/maternal boundary.
Ekström TJ; Cui H; Nyström A; Rutanen EM; Ohlsson R
Mol Reprod Dev; 1995 Jun; 41(2):177-83. PubMed ID: 7654371
[TBL] [Abstract][Full Text] [Related]
36. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
[TBL] [Abstract][Full Text] [Related]
37. Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors.
Okutsu T; Kuroiwa Y; Kagitani F; Kai M; Aisaka K; Tsutsumi O; Kaneko Y; Yokomori K; Surani MA; Kohda T; Kaneko-Ishino T; Ishino F
J Biochem; 2000 Mar; 127(3):475-83. PubMed ID: 10731720
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
Okamoto K; Morison IM; Taniguchi T; Reeve AE
Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243
[TBL] [Abstract][Full Text] [Related]
39. Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Morison IM; Becroft DM; Reeve AE
J Natl Cancer Inst; 2002 Dec; 94(23):1809; author reply 1809-10. PubMed ID: 12464656
[No Abstract] [Full Text] [Related]
40. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
